Shukla Arun K, Kumari Punita, Ghosh Eshan, Nidhi Kumari
Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, India.
Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, India.
Methods Enzymol. 2015;556:549-61. doi: 10.1016/bs.mie.2015.01.017. Epub 2015 Mar 21.
G protein-coupled receptors (GPCRs) are the primary targets of drugs prescribed for many human pathophysiological conditions such as hypertension, allergies, schizophrenia, asthma, and various types of cancer. High-resolution structure determination of GPCRs has been a key focus area in GPCR biology to understand the basic mechanism of their activation and signaling and to materialize the long-standing dream of structure-based drug design on these versatile receptors. There has been tremendous effort at this front in the past two decades and it has culminated into crystal structures of 27 different receptors so far. The recent progress in crystallization and structure determination of GPCRs has been driven by innovation and cutting-edge developments at every step involved in the process of crystallization. Here, we present a step-by-step description of various steps involved in GPCR crystallization starting from recombinant expression to obtaining diffracting crystals. We also discuss the next frontiers in GPCR biology that are likely to be a primary focus for crystallography efforts in the next decade or so.
G蛋白偶联受体(GPCRs)是许多人类病理生理状况(如高血压、过敏、精神分裂症、哮喘和各类癌症)所开药物的主要靶点。GPCRs的高分辨率结构测定一直是GPCR生物学的关键重点领域,以了解其激活和信号传导的基本机制,并实现基于结构的药物设计这一长期以来对这些多功能受体的梦想。在过去二十年里,这方面付出了巨大努力,迄今为止已产生了27种不同受体的晶体结构。GPCRs结晶和结构测定的最新进展是由结晶过程中每个步骤的创新和前沿发展推动的。在此,我们逐步描述从重组表达到获得衍射晶体的GPCR结晶所涉及的各个步骤。我们还讨论了GPCR生物学的下一个前沿领域,这些领域可能是未来十年左右晶体学研究的主要重点。